Insights

Market commentary and guides

  • Global Macro

    Today’s NY close will mark both the end of September and the end of the third quarter of 2016. Often times, these month-end, quarter-end…

  • Resmed – Buying Opportunity

    Out of the three healthcare buy recommendations, (CSL, SHL and RMD),   made in the blog post back on 13th of September, CSL has increased 10% and SHL 10%+, however, RMD…

  • Oil Search – Price Bounces Following OPEC Agreement

    Oil Search (OSH.ASX) remains an attractive recovery story over the next few months with a potential price target back above $7.25. This target is seen…

  • Medibank – Is Value Emerging?

    Medibank (MPL.ASX) is now trading at a price level that warrants attention. The stock is forecast to pay a fully franked dividend in FY17…

  • ASX Mid-Week – Video Update

    I’ve decided this week to replace the usual multiple individual posts with a quick summary video. I think this does a better job of…

  • Global Macro

    With global financial markets firmly focused on central bank meetings in the US and Japan last week, it was easy to overlook the bad news delivered…

  • Global Macro

    While there was never a consensus that the FED was going to lift the overnight target rate going into last week’s FOMC meeting, there were…

  • Global Macro

    The BoJ also announced that they would maintain its JPY 6 trillion a year purchases of equity exchange traded funds (ETFs), but widened the distribution…

  • XJO Index Watch – Key Levels you Should be Tracking

    Following last night’s decision in the US to leave rates unchanged, yield stocks will begin their recovery as we forecasted. See our list of…

  • Navitas – Get Ready to Take Profit

    Navitas (NVT.ASX)  was recommended as a buy on the 15th August with an entry level at $5.00. The stock has rallied 5% plus, in a…